23.Pain in Patients with Cancer

Pain Practice

Volumn 11, Issue 5, 2011, Pages 453-475

  Vissers, Kris C P ^a   Besse, Kees ^a   Wagemans, Michel ^b   Zuurmond, Wouter ^c   Giezeman, Maurice J M M ^d   Lataster, Arno ^e   Mekhail, Nagy ^f   Burton, Allen W ^g   van Kleef, Maarten ^h   Huygen, Frank ⁱ  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Anesthesiology and Pain Management   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DEPARTMENT OF SURGERY   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Cordotomy; Epidural; Evidence based medicine; Intrathecal; Kyphoplasty; Lower end block; Nervus splanchnicus block; Plexus coeliacus block; Plexus hypogastricus block; Saddle block; Vertebroplasty

Indexed keywords

BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; LEVOBUPIVACAINE; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE; ROPIVACAINE;

ARTICLE; BLADDER DYSFUNCTION; BLEEDING; CANCER PAIN; CANCER PATIENT; CANCER SURGERY; CATHETER INFECTION; COMPRESSION FRACTURE; CORDOTOMY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSESTHESIA; EPIDURAL CATHETER; HEADACHE; HEMATURIA; HUMAN; HYPOGONADISM; HYPOTENSION; KYPHOPLASTY; LIFE EXPECTANCY; MUSCLE WEAKNESS; NECK PAIN; NERVE BLOCK; NERVE STIMULATION; NERVUS SPLANCHNICUS BLOCK; NEUROPATHIC PAIN; PAIN ASSESSMENT; PANCREAS CANCER; PARESIS; PARESTHESIA; PATIENT SAFETY; PELVIS PAIN SYNDROME; PELVIS TUMOR; PERCUTANEOUS VERTEBROPLASTY; PERINEUM PAIN; PLEXUS COELIACUS BLOCK; PLEXUS HYPOGASTRICUS BLOCK; PNEUMOTHORAX; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RESPIRATION DEPRESSION; SHOULDER PAIN; SPINAL CORD STIMULATION; SPINAL PAIN; STOMACH CANCER; UPPER ABDOMINAL PAIN; VISCERAL PAIN;

EID: 80052965565     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2011.00473.x     Document Type: Article

References (59)

1. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006;129:174-181.
2. van Kleef M, Mekhail N, van Zundert J. Evidence-based guidelines for interventional pain medicine according to clinical diagnoses. Pain Pract. 2009;9:247-251.
3. Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann N Y Acad Sci. 2008;1138:299-328.
4. Landelijke richtlijnwerkgroep Pijn bij kanker. Pijn bij kanker. Landelijke richtlijn. In: Landelijke richtlijnwerkgroep Pijn bij kanker. 2008: 1-168. ISBN: 978-90-8523-168-4.
5. Ballantyne JC, Carwood CM. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database Syst Rev. 2005;1:CD005178.
6. Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, David F, et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain. 2007;23:793-798.
7. Pasutharnchat K, Tan KH, Abdul Hadi M, Ho KY. Intrathecal analgesia in patients with cancer pain - an audit in a tertiary institution. Ann Acad Med Singapore. 2009;38:943-946.
8. Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA. 2004;291:63-70.
9. Raffaeli W, Sarti D, Demartini L, Sotgiu A, Bonezzi C. Italian registry on long-term intrathecal ziconotide treatment. Pain Physician. 2011;14:15-24.
10. Stearns L, Boortz-Marx R, Du Pen S, et al. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol. 2005;3:399-408.
11. Krames ES. Practical issues when using neuraxial infusion. Oncology (Williston Park). 1999;13:37-44.
12. De Pinto M, Dunbar PJ, Edwards WT. Pain management. Anesthesiol Clin. 2006;24:19-37 vii.
13. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999;79:1-13.
14. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology. 2003;99:174-187.
15. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab. 2000;85:2215-2222.
16. Ruppen W, Derry S, McQuay HJ, Moore RA. Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis. BMC Palliat Care. 2007;6:3.
17. Aprili D, Bandschapp O, Rochlitz C, Urwyler A, Ruppen W. Serious complications associated with external intrathecal catheters used in cancer pain patients: a systematic review and meta-analysis. Anesthesiology. 2009;111:1346-1355.
18. Mullan S, Lichtor T. Percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia. J Neurosurg. 1983;59:1007-1012.
19. Boersma F, Van Kleef M, Rohof O, Stolker R, Touw P, Zuurmond W. Richtlijnen anesthesiologische pijnbestrijding. Groningen, The Netherlands: Drukkerij van Denderen BV; 1996. ISBN: 90-71353-06-0.
20. Zuurmond WW, Perez RS, Loer SA. Role of cervical cordotomy and other neurolytic procedures in thoracic cancer pain. Curr Opin Support Palliat Care. 2010;4:6-10.
21. Nagaro T, Amakawa K, Yamauchi Y, Tabo E, Kimura S, Arai T. Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome. Pain. 1994;58:325-330.
22. Amano K, Kawamura H, Tanikawa T, et al. Bilateral vs. unilateral percutaneous high cervical cordotomy as a surgical method of pain relief. Acta Neurochir Suppl (Wien). 1991;52:143-145.
23. Crul BJ, Blok LM, van Egmond J, van Dongen RT. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain. 2005;6:24-29.
24. Jackson MB, Pounder D, Price C, Matthews AW, Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax. 1999;54:238-241.
25. Sanders M, Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol. 1995;13:1509-1512.
26. Slavik E, Ivanovic S, Grujisic D, Djurovic B, Nikolic I. Microsurgical spinothalamic chordotomy in the treatment of cancer pain. J Buon. 2005;10:223-226.
27. Stuart G, Cramond T. Role of percutaneous cervical cordotomy for pain of malignant origin. Med J Aust. 1993;158:667-670.
28. Meeuse JJ, Vervest AC, van der Hoeven JH, Reyners AK. Five-year follow-up of a cordotomy. Pain Res Manag.. 2008;13:506-510.
29. Raslan AM. Percutaneous computed tomography-guided radiofrequency ablation of upper spinal cord pain pathways for cancer-related pain. Neurosurgery. 2008;62:226-233 discussion 233-224.
30. Kanpolat Y, Ugur HC, Ayten M, Elhan AH. Computed tomography-guided percutaneous cordotomy for intractable pain in malignancy. Neurosurgery. 2009;64:187-193 discussion 193-184.
31. Jones B, Finlay I, Ray A, Simpson B. Is there still a role for open cordotomy in cancer pain management? J Pain Symptom Manage. 2003;25:179-184.
32. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290-295.
33. Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol. 2007;102:430-438.
34. Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291:1092-1099.
35. Zhang CL, Zhang TJ, Guo YN, et al. Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain. Dig Dis Sci. 2008;53:856-860.
36. Johnson CD, Berry DP, Harris S, et al. An open randomized comparison of clinical effectiveness of protocol-driven opioid analgesia, celiac plexus block or thoracoscopic splanchnicectomy for pain management in patients with pancreatic and other abdominal malignancies. Pancreatology. 2009;9:755-763.
37. Suleyman Ozyalcin N, Talu GK, Camlica H, Erdine S. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Eur J Pain. 2004;8:539-545.
38. Abdalla EK, Schell SR. Paraplegia following intraoperative celiac plexus injection. J Gastrointest Surg. 1999;3:668-671.
39. Kumar A, Tripathi SS, Dhar D, Bhattacharya A. A case of reversible paraparesis following celiac plexus block. Reg Anesth Pain Med. 2001;26:75-78.
40. van Dongen RT, Crul BJ. Paraplegia following coeliac plexus block. Anaesthesia. 1991;46:862-863.
41. Pello S, Miller A, Ku T, Wang D. Hemorrhagic gastritis and duodenitis following celiac plexus neurolysis. Pain Physician. 2009;12:1001-1003.
42. Plancarte-Sanchez R, Mayer-Rivera F, del Rocio Guillen Nunez M, Guajardo-Rosas J, Acosta-Quiroz CO. Transdiscal percutaneous approach of splanchnic nerves. Cir Cir. 2003;71:192-203.
43. Abram SE, Boas R. Sympathetic and visceral nerve blocks. In: Benumof J, ed. Clinical Procedures in Anesthesia and Intensive Care. Philadelphia: Lippincott; 1992: 787.
44. Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997;22:562-568.
45. de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain. 2004;110:400-408.
46. Plancarte RS, Mayer-Rivera FJ. Radiofrequency procedures for sacral and pelvic region pain. Pain Practice. 2002;2:248-249.
47. Cousins M, Bridenbaugh P. Neural Blockade in Clinical Anesthesia and Management of Pain. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
48. deLeon Casasola O. Cancer Pain: Pharmacological, Interventional, and Palliative Approaches. 1st ed. Philadelphia: Saunders Elsevier; 2006.
49. Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol. 2003;17:407-428.
50. Rodriguez-Bigas M, Petrelli NJ, Herrera L, West C. Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. Surg Gynecol Obstet. 1991;173:41-44.
51. Slatkin NE, Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care. 2003;20:62-66.
52. Dahan A, Yassen A, Bijl H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth. 2005;94:825-834.
53. Peh WC, Munk PL, Rashid F, Gilula LA. Percutaneous vertebral augmentation: vertebroplasty, kyphoplasty and skyphoplasty. Radiol Clin North Am. 2008;46:611-635 vii.
54. Kvarstein G, Mawe L, Indahl A, et al. A randomized double-blind controlled trial of intra-annular radiofrequency thermal disc therapy - a 12-month follow-up. Pain. 2009;145:279-286.
55. Bae H, Shen M, Maurer P, et al. Clinical experience using Cortoss for treating vertebral compression fractures with vertebroplasty and kyphoplasty: twenty-four-month follow-up. Spine (Phila Pa 1976). 2010;35:E1030-E1036.
56. Lim BS, Chang UK, Youn SM. Clinical outcomes after percutaneous vertebroplasty for pathologic compression fractures in osteolytic metastatic spinal disease. J Korean Neurosurg Soc. 2009;45:369-374.
57. McKiernan F, Faciszewski T, Jensen R. Quality of life following vertebroplasty. J Bone Joint Surg Am. 2004;86-A:2600-2606.
58. McGraw JK, Cardella J, Barr JD, et al. Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol. 2003;14:S311-S315.
59. Gangi A, Sabharwal T, Irani FG, Buy X, Morales JP, Adam A. Quality assurance guidelines for percutaneous vertebroplasty. Cardiovasc Intervent Radiol. 2006;29:173-178.